John Vacalis is listed as an executive officer on 1 SEC Form D filing by 1 issuer in Dec 2022: Direct Biologics, LLC (Austin, TX — biotechnology — 2022; $11.6M reported sold to 116 investors).
What this means One deal on file with the SEC, filed Dec 2022. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for John Vacalis and found 3 differences, 2 worth asking the sponsor about: Paid seller listed without a CRD number: IB Capital LLC; Form D filed 67 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.